Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:33 AM UTC
| NCT Number | NCT06855498 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 106 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06855498 is currently recruiting participants. This phase3 study for hidradenitis suppurativa is actively seeking new participants at 106 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06855498 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 106 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06855498 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.